C. Bancher et al., NEUROPATHOLOGIC DIAGNOSIS OF ALZHEIMER-DISEASE - CONSENSUS BETWEEN PRACTICING NEUROPATHOLOGISTS, Alzheimer disease and associated disorders, 11(4), 1997, pp. 207-219
In an attempt to gather information on procedures, criteria, and possi
ble difficulties, we have sent a detailed questionnaire on the postmor
tem diagnosis of Alzheimer disease (AD) to 169 neuropathologists in th
e German-speaking countries-Germany Austria, and Switzerland. Of a tot
al of 104 responses, 65 completed questionnaires were evaluated statis
tically. Fifty-nine percent of all respondents consider the neuropatho
logic diagnosis of AD a problem. Although 38% consider themselves able
to establish the diagnosis without knowledge of clinical data, 29% do
not believe this is possible. Thirty-eight percent opine that the pre
sence of neurofibrillary tangles is not a prerequisite for a positive
diagnosis, and 3% believe that examination of the hippocampal formatio
n is unnecessary. For 6% of the respondents, neither a, silver stain n
or thioflavin S is necessary. Ninety-seven percent believe that the av
ailability of explicit diagnostic criteria would be helpful; by contra
st, only 43% have exact knowledge of the National institute of Aging c
riteria, and only 29% have exact knowledge of the Consortium to Establ
ish a Registry for Alzheimer's Disease (CERAD) criteria. Only every fo
urth neuropathologist uses these criteria regularly and the validity o
f current diagnostic criteria is challenged by a considerable number o
f respondents. Many pathologists consider the quantification of plaque
s and tangles problematic, are confused by a lacking correlation of th
e pathology with the clinical picture, and believe that the gray zone
between normal aging and full-fledged AD represents a major diagnostic
problem. Our survey shows that there currently is no consensus on dia
gnostic procedures and criteria used in practice. This stresses the ne
ed for precise diagnostic guidelines and continuing information of act
ively practicing neuropathologists to achieve higher interlaboratory r
eliability of the diagnosis of AD.